comparemela.com

Latest Breaking News On - Tonix pharmaceuticals price performance - Page 1 : comparemela.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Scheduled to Reverse Split on Monday, June 10th

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Free Report) shares are going to reverse split on the morning of Monday, June 10th. The 1-32 reverse split was announced on Thursday, June 6th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, June 7th. Tonix Pharmaceuticals Price Performance Shares of […]

Zembrace-symtouch
Dawson-james
Tonix-pharmaceuticals-price-performance
Tonix-pharmaceuticals
Nasdaq
News-ratings-for-tonix-pharmaceuticals-daily
Institutional-trading-of-tonix-pharmaceuticals
Acadian-asset-management
Armistice-capital
Sabby-management
Tonix-pharmaceuticals-holding-corp
Tonix-pharmaceuticals-holding

StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)

Equities researchers at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock. Separately, Dawson James began coverage on shares of Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a “buy” rating and a […]

Zembrace-symtouch
Dawson-james
Tonix-pharmaceuticals-company-profile
News-ratings-for-tonix-pharmaceuticals-daily
Armistice-capital
Hedge-funds-weigh-in-on-tonix-pharmaceuticals
Sabby-management
Tonix-pharmaceuticals
Tonix-pharmaceuticals-holding-corp
Tonix-pharmaceuticals-price-performance
Acadian-asset-management
Get-free-report

Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock. Separately, Dawson James initiated coverage on Tonix Pharmaceuticals in a research report on Wednesday, February 28th. They set a buy rating and a $3.00 price […]

Dawson-james
Zembrace-symtouch
Institutional-investors-weigh-in-on-tonix-pharmaceuticals
Tonix-pharmaceuticals-holding-corp
Tonix-pharmaceuticals-price-performance
Tonix-pharmaceuticals
Armistice-capital
Acadian-asset-management
News-ratings-for-tonix-pharmaceuticals-daily
Sabby-management
Free-report
Get-free-report

Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Tuesday morning. The firm issued a sell rating on the stock. Separately, Dawson James assumed coverage on Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a buy rating and a $3.00 target […]

Dawson-james
Zembrace-symtouch
Tonix-pharmaceuticals-holding-corp
Jpmorgan-chase-co
Tonix-pharmaceuticals-price-performance
News-ratings-for-tonix-pharmaceuticals-daily
Hedge-funds-weigh-in-on-tonix-pharmaceuticals
Raymond-james-associates
Tonix-pharmaceuticals
Virtu-financial
Free-report
Sigma-investments

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.